These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1275776)

  • 1. [Histochemical properties of the heparin-protein complex of mast cells and the state of the blood coagulating system in a primary lesion focus of non-specific ulcerative colitis].
    Shubnich MG; Lopunova ZhK; Karbovnitskaia LP; Litvinenko MD
    Arkh Patol; 1976; 38(2):60-5. PubMed ID: 1275776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histochemical characteristics of mast cells in hemangiomas].
    Shubich MG; Lopunova ZhK; Shul'zhenko VI
    Arkh Patol; 1976; 38(12):32-5. PubMed ID: 1016087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin.
    Samoszuk M; Corwin M; Yu H; Wang J; Nalcioglu O; Su MY
    Thromb Haemost; 2003 Aug; 90(2):351-60. PubMed ID: 12888884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N
    Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mast cells in ulcerative colitis].
    Balázs M; Illyés G; Vadász G
    Morphol Igazsagugyi Orv Sz; 1989 Jul; 29(3):161-9. PubMed ID: 2797015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absorption function of the large intestine in patients with nonspecific ulcerative colitis].
    Osina VA; Rogozina VA; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2002; (2):88-91, 104. PubMed ID: 12046397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell heterogeneity between two different species of Hoplias sp. (Characiformes: Erythrinidae): response to fixatives, anatomical distribution, histochemical contents and ultrastructural features.
    Rocha JS; Chiarini-Garcia H
    Fish Shellfish Immunol; 2007 Mar; 22(3):218-29. PubMed ID: 16824768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
    Shimonaeva EE; Andreenko GV
    Vopr Med Khim; 1988; 34(1):59-62. PubMed ID: 3130724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible causes of the heterogeneity of the histochemical properties of tissue basophils].
    Lopunova ZhK; Gordon DS
    Arkh Anat Gistol Embriol; 1986 Dec; 91(12):78-81. PubMed ID: 3827615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peculiarities of the ultrastructural organization of prismatic cells of the large intestine in nonspecific ulcerative colitis].
    Gokhberg SL; Rasulev NI
    Arkh Patol; 1975; 37(4):55-60. PubMed ID: 1200875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of microcirculatory factors in cancer metastasis].
    Tsyplakov DE; Ziganshina LE
    Vopr Onkol; 1988; 34(8):932-6. PubMed ID: 3420836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting.
    Samoszuk M; Corwin M; Hazen SL
    Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical response to heparin in 10 patients with ulcerative colitis.
    Gaffney PR; Doyle CT; Gaffney A; Hogan J; Hayes DP; Annis P
    Am J Gastroenterol; 1995 Feb; 90(2):220-3. PubMed ID: 7847289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Features of mast cell status and blood coagulation during long-term administration of noradrenaline in mountain dogs].
    Frolenko VI; Isabaeva VA; Zakharov GA; Gorokhova GI; Novikova NP
    Biull Eksp Biol Med; 1993 Feb; 115(2):123-5. PubMed ID: 8043778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
    Andoh A; Deguchi Y; Inatomi O; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Jul; 16(1):103-7. PubMed ID: 16786130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression in histologically normal crypts of ulcerative colitis suggests primary crypt disorder.
    Kim M; Lee S; Yang SK; Song K; Lee I
    Oncol Rep; 2006 Oct; 16(4):663-70. PubMed ID: 16969477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some histochemical aspects of the large intestine epithelium in nonspecific ulcerative colitis].
    Levin VN; Zabelina TN
    Vestn Akad Med Nauk SSSR; 1966; 21(10):79-86. PubMed ID: 4233047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.